Literature DB >> 14527161

Perisynaptic barrier of proteoglycans in the mature brain and spinal cord.

Takuro Murakami1, Aiji Ohtsuka.   

Abstract

Cell bodies and their dendrites of motor neurons, motor-related neurons, and certain other subsets of neurons such as GABAergic interneurons in the mature brain and spinal cord possess intensely negatively charged perineuronal or perisynaptic nets of proteoglycans which are linked to the nerve cell surface glycoproteins. These perineuronal nets of proteoglycans are digested by chondroitinase ABC, hyaluronidase, or collagenase, but not by endo-alpha-N-acetylgalactosaminidase, which is reactive to the nerve cell surface glycoproteins. Aggrecan, versican, neurocan, and brevican are members of a family of chondroitin sulfate proteoglycans that bind to hyaluronan. Neurocan- or brevican-deficient mice showed a regionally heterogeneous composition of proteoglycans in perineuronal nets. Aggrecan glycoforms contribute to the molecular heterogeneity of the perineuronal nets. Proteoglycans such as phosphacan are included in matrix-associated proteoglycans. The extracellular matrix glycoprotein tenascin-R is accumulated in the perineuronal nets. The perineuronal proteoglycans are produced by associated satellite astrocytes just before weaning, while the nerve cell surface glycoproteins are produced by the associated nerve cells at earlier stages after birth. The perineuronal proteoglycans may entrap the tissue fluid and form a perineuronal gel layer which protects the synapses as a "perisynaptic barrier". Degradation of the perineuronal proteoglycans or perisynaptic barrier by treatment with chondroitinase ABC or hyaluronidase reactivates the neuronal plasticity or promotes the functional recovery of a severed nervous system. Another set of perineuronal nets occurs, which are intensely positively charged and contain guanidino compounds. It is considered that these intensely positively charged nets are intermingled with the intensely negatively charged ones of proteoglycans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14527161     DOI: 10.1679/aohc.66.195

Source DB:  PubMed          Journal:  Arch Histol Cytol        ISSN: 0914-9465


  9 in total

1.  Extracellular matrix plasticity and GABAergic inhibition of prefrontal cortex pyramidal cells facilitates relapse to heroin seeking.

Authors:  Michel C Van den Oever; Bart R Lubbers; Natalia A Goriounova; Ka W Li; Roel C Van der Schors; Maarten Loos; Danai Riga; Joost Wiskerke; Rob Binnekade; M Stegeman; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Taco J De Vries; Sabine Spijker
Journal:  Neuropsychopharmacology       Date:  2010-06-30       Impact factor: 7.853

Review 2.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

Review 3.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

4.  The Number of Chandelier and Basket Cells Are Differentially Decreased in Prefrontal Cortex in Autism.

Authors:  Jeanelle Ariza; Haille Rogers; Ezzat Hashemi; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Cereb Cortex       Date:  2018-02-01       Impact factor: 5.357

5.  Subpopulations of neurons expressing parvalbumin in the human amygdala.

Authors:  Harry Pantazopoulos; Nicholas Lange; Linda Hassinger; Sabina Berretta
Journal:  J Comp Neurol       Date:  2006-06-10       Impact factor: 3.215

6.  An immunohistochemical study of matrix proteins in the craniofacial cartilage in midterm human fetuses.

Authors:  S Shibata; Y Sakamoto; O Baba; C Qin; G Murakami; B H Cho
Journal:  Eur J Histochem       Date:  2013-12-02       Impact factor: 3.188

7.  Hyaluronan synthesis by developing cortical neurons in vitro.

Authors:  Tania M Fowke; Rashika N Karunasinghe; Ji-Zhong Bai; Shawn Jordan; Alistair J Gunn; Justin M Dean
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

8.  Differential distribution of aggrecan isoforms in perineuronal nets of the human cerebral cortex.

Authors:  Daniela Virgintino; Daniela Perissinotto; Francesco Girolamo; Maria T Mucignat; Luisa Montanini; Mariella Errede; Tomoyuki Kaneiwa; Shushei Yamada; Kazuyuki Sugahara; Luisa Roncali; Roberto Perris
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

9.  Limitations and Challenges in Modeling Diseases Involving Spinal Motor Neuron Degeneration in Vitro.

Authors:  Monica Bucchia; Samantha J Merwin; Diane B Re; Shingo Kariya
Journal:  Front Cell Neurosci       Date:  2018-03-06       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.